R228060

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R228060, covering 2009-08-28 to 2009-08-28. Get the full timeline:

Most recent: Clinical Trial Update: A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder [Phase 2]

See pricing